Tween 80 Micelles Loaded with Fe3O4 Nanoparticles and Artemisinin for Combined Oxygen-Independent Ferroptosis Therapy of Cancer

Junming Cui,Xinxi Cai,Rui Qian,Lin Wu,Xueyong Qi,Jin Cao,Song Shen

DOI: https://doi.org/10.3390/pharmaceutics16050639

IF: 6.525

2024-05-10

Pharmaceutics

Abstract:Artemisinin has an endoperoxide bridge structure, which can be cleaved by ferrous ions to generate various carbonyl radicals in an oxygen-independent manner, highlighting its potential for treating hypoxic tumors. In our study, we fabricated Tween 80 micelles loaded with Fe3O4 nanoparticles and artemisinin for cancer therapy. The synthesized Fe3O4 nanoparticles and drug-loaded micelles have particle sizes of about 5 nm and 80 nm, respectively, both exhibiting excellent dispersibility and stability. After uptake by MCF-7 cells, drug-loaded micelles release Fe2+ and ART into the cytoplasm, effectively inducing the generation of reactive oxygen species (ROS) in hypoxic conditions, thereby enhancing toxicity against cancer cells. In vitro and in vivo studies have demonstrated that ART and Fe3O4 nanoparticles are encapsulated in Tween 80 to form micelles, which effectively prevent premature release during circulation in the body. Although free ART and Fe3O4 nanoparticles can inhibit tumor growth, TW80-Fe3O4-ART micelles demonstrate a more pronounced inhibitory effect, with a tumor suppression rate of up to 85%. A novel strategy based on artemisinin and ferroptosis is thus offered, holding a favorable prospect for hypoxic cancer therapy.

pharmacology & pharmacy

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to improve the therapeutic effect of ferroptosis therapy on cancer in a hypoxic environment. Specifically, by constructing Tween 80 micelles containing Fe_3O_4 nanoparticles and artemisinin (ART), the researchers achieved an oxygen - independent ferroptosis therapy, aiming to enhance the toxic effect on hypoxic tumor cells. This method takes advantage of the characteristic that artemisinin can generate free radicals under the catalysis of iron ions, and can effectively kill cancer cells even under low - oxygen conditions, thus overcoming the problem of weakened efficacy of traditional ferroptosis therapy in a hypoxic environment. The research results show that this new type of composite micelle exhibits a significant anti - tumor effect in both in - vivo and in - vitro experiments, and the tumor inhibition rate can be as high as 85%. This provides a new strategy for the treatment of hypoxic cancers.